UNMC_Acronym_Vert_sm_4c
University of Nebraska Medical Center

Updated COVID booster tied to strong Omicron immune response

CIDRAP – The new bivalent (two-strain) Moderna COVID-19 vaccine booster triggered stronger neutralizing antibody responses against the highly transmissible Omicron variant at 28 days than the previously authorized booster, with no safety concerns, according to the interim results of a phase 2/3 open-label, nonrandomized study published late last week in the New England Journal of Medicine.

Leave a comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.